Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2015-07-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males
NCT02214290
Assessment of Short-term Effect of L-Citrulline on Endothelial Function and Vasodilation in Known CAD Patients
NCT02638727
Effects of Oral Antioxidant Cocktail in Cardiovascular Disease Patients
NCT03629613
Effect of Polyphenols Combined to L-citrulline on Ambulatory Blood Pressure
NCT03679195
The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease
NCT01917123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CitrullinePlacebo
Subjects allocated to the CitrullinePlacebo study arm received L-citrulline first, followed by placebo.
L-citrulline
L-citrulline capsules given at 6 g/day
Placebo
Maltodextrin capsules given as placebo
PlaceboCitrulline
Subjects allocated to the PlaceboCitrulline study arm received placebo first, followed by L-citrulline.
L-citrulline
L-citrulline capsules given at 6 g/day
Placebo
Maltodextrin capsules given as placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-citrulline
L-citrulline capsules given at 6 g/day
Placebo
Maltodextrin capsules given as placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* women and men
* aged 60-79 yrs
* must be able to swallow capsules
* fully mobile without assistive walking devices
Exclusion Criteria
* are current smokers
* currently taking medications affecting cardiovascular function
* have high blood pressure (\>159/99 mmHG)
* have high fasting blood glucose (\>110 mg/dL)
* are considered obese (body mass index ≥ 30 kg/m2)
* have orthopaedic limitations that limit walking ability
* have pacemaker or other metal objects in their body
60 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
Texas Tech University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joaquin U Gonzales, PhD
Associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15BGIA22710012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.